Aspira Women's Health Inc. (AWHL) › Cash & EquivalentsAspira Women's Health Inc. (AWHL) — Cash & EquivalentsAnnual figures by period end, from SEC filings.2009-12-31: $3.44M2010-12-31: $22.91M2011-12-31: $22.48M2012-12-31: $8.01M2013-12-31: $29.50M2014-12-31: $22.96M2015-12-31: $18.64M2016-12-31: $5.24M2017-12-31: $5.54M2020-12-31: $16.63M2021-12-31: $37.18M2022-09-30: $20.55M2022-12-31: $13.31M2023-12-31: $2.60M2024-12-31: $1.77M2025-12-31: $1.75M$1.75M2009-12-31Cash & Equivalents (USD)2025-12-31Period endedCash & EquivalentsChange YoYSource filing2025-12-31$1.75M-0.8%2026-04-01Balance as of period end2024-12-31$1.77M-31.9%2026-04-01Balance as of period end2023-12-31$2.60M-80.5%2025-03-27Balance as of period end2022-12-31$13.31M—2024-04-01Balance as of period end2022-09-30$20.55M—2023-10-26Balance as of period end2021-12-31$37.18M+123.6%2023-10-26Balance as of period end2020-12-31$16.63M—2022-03-31Balance as of period end2017-12-31$5.54M+5.7%2018-03-13Balance as of period end2016-12-31$5.24M-71.9%2018-03-13Balance as of period end2015-12-31$18.64M-18.8%2018-03-13Balance as of period end2014-12-31$22.96M-22.2%2017-03-31Balance as of period end2013-12-31$29.50M+268.5%2016-03-30Balance as of period end2012-12-31$8.01M-64.4%2015-03-31Balance as of period end2011-12-31$22.48M-1.9%2014-03-31Balance as of period end2010-12-31$22.91M+566.1%2013-03-01Balance as of period end2009-12-31$3.44M—2012-03-27Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)